Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 USD | +4.46% | +4.93% | -38.90% |
Evolution of the average Target Price on Acurx Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Acurx Pharmaceuticals, Inc.
HC Wainwright | |
Maxim | |
Alliance Global Partners |
EPS Revisions
- Stock Market
- Equities
- ACXP Stock
- Consensus Acurx Pharmaceuticals, Inc.